BMRN

NASDAQ · Biotechnology

Biomarin Pharmaceutical Inc

Large-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks

$63.94

-1.14 (-1.75%)

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 27 77%

Hold 8 23%

Sell 0 0%

Price Target

Analyst Price Target +97.7% upside

Low Target $89.21

Average Target $126.44

High Target $194.19

Current Price $63.94

Current
$63.94

Target
$126.44

$89.21 $126.44 avg $194.19

Scenario Analysis

Bear Case

$89.21

39.5%

Low target

Base Case

$126.44

+97.7%

Avg target

Bull Case

$194.19

+203.7%

High target

Risk/Reward

5.2x

Highly favorable

Price in Context

52-Week High

$70.98

-9.9% from high

52-Week Low

$49.26

+29.8% from low

50-Day SMA

$58.45

+9.4% vs SMA

200-Day SMA

$56.57

+13.0% vs SMA

RSI (14)

78.3

Overbought

Target vs 52W High

$126.44

+78.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.4%
AMGN Amgen Inc	Hold	43	47%	$190.87	-50.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-13.8%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.2%
MRNA Moderna Inc	Hold	30	37%	$149.45	-3.0%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-61.3%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.2%